בנק אוף אמריקה (BofA) החליט לכלול את Intuitive Surgical ב”רשימת ארה”ב 1″ שלו, שהיא קבוצה של הבחירות המועדפות ביותר שמומלצות על ידי אנליסטי הבנק. כל המניות הללו מדורגות כ”קנייה” ורשומות
בנק אוף אמריקה (BofA) החליט לכלול את Intuitive Surgical ב”רשימת ארה”ב 1″ שלו, שהיא קבוצה של הבחירות המועדפות ביותר שמומלצות על ידי אנליסטי הבנק. כל המניות הללו מדורגות כ”קנייה” ורשומות
BofA is adding Intuitive Surgical (ISRG) to the firm’s “US 1 List,” which it says is intended to represent a collection of the firm’s best investment ideas drawn from the
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ionis Pharmaceuticals (IONS – Research Report), Intuitive Surgical (ISRG – Research Report) and Karyopharm Therapeutics (KPTI – Research Report) with bullish sentiments.
Ionis Pharmaceuticals (IONS)
Needham analyst Joseph Stringer maintained a Buy rating on Ionis Pharmaceuticals today and set a price target of $60.00. The company’s shares closed last Monday at $42.24.
According to TipRanks.com, Stringer is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ionis Pharmaceuticals with a $58.50 average price target, implying a 34.7% upside from current levels. In a report released yesterday, Citi also maintained a Buy rating on the stock with a $60.00 price target.
See the top stocks recommended by analysts >>
Intuitive Surgical (ISRG)
J.P. Morgan analyst Robbie Marcus maintained a Buy rating on Intuitive Surgical today and set a price target of $475.00. The company’s shares closed last Monday at $386.93, close to its 52-week high of $403.76.
According to TipRanks.com, Marcus is a 5-star analyst with an average return of
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $420.44, implying an 8.3% upside from current levels. In a report issued on April 3, Citi also maintained a Buy rating on the stock with a $462.00 price target.
Karyopharm Therapeutics (KPTI)
RBC Capital analyst Brian Abrahams maintained a Buy rating on Karyopharm Therapeutics on April 4 and set a price target of $3.00. The company’s shares closed last Monday at $1.35.
According to TipRanks.com, Abrahams is a 5-star analyst with an average return of
Currently, the analyst consensus on Karyopharm Therapeutics is a Strong Buy with an average price target of $5.80.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on IONS:
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ionis Pharmaceuticals (IONS – Research Report) and Intuitive Surgical (ISRG – Research Report) with bullish sentiments.
Ionis Pharmaceuticals (IONS)
Wells Fargo analyst Yanan Zhu maintained a Buy rating on Ionis Pharmaceuticals today. The company’s shares closed last Monday at $42.24.
According to TipRanks.com, Zhu is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ionis Pharmaceuticals with a $58.50 average price target, representing a 34.7% upside. In a report released today, Citi also maintained a Buy rating on the stock with a $60.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Intuitive Surgical (ISRG)
In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Intuitive Surgical, with a price target of $416.00. The company’s shares closed last Monday at $386.93, close to its 52-week high of $403.76.
According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $420.44, implying an 8.3% upside from current levels. In a report issued on April 3, Citi also maintained a Buy rating on the stock with a $462.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on IONS:
Stifel analyst Rick Wise raised the firm’s price target on Intuitive Surgical to $430 from $420 and keeps a Buy rating on the shares after having hosted an investor dinner